Accuray (NASDAQ: ARAY) delivered a mixed fourth-quarter fiscal 2026 performance, posting an earnings-per-share beat alongside a significant revenue miss. The medical technology company reported a quarterly loss of $(0.02) per share, surpassing the analyst consensus estimate of $(0.10) by 80 percent. This result represents a 300 percent decrease in earnings compared to the $0.01 per share recorded in the same period last year.

Despite the improvement in EPS against expectations, top-line growth remained under pressure. Accuray reported quarterly sales of $100.9 million, which missed the analyst consensus estimate of $105.3 million by 4.16 percent. This figure marks a 21 percent decrease from the $127.543 million in sales generated during the same period last year. Full-year revenue for fiscal 2026 was $402 million, down 12 percent from the prior year.

Strategic Financial Restructuring

To strengthen its financial position, Accuray entered into a comprehensive transaction with TCW Asset Management. The deal involves converting $40 million of existing debt into preferred equity and securing a $15 million cash investment in additional convertible preferred equity. The transaction also includes a delayed draw facility and a covenant holiday through December 2027. These measures are designed to improve liquidity, reduce leverage, and provide greater runway for strategic execution. Certain elements, including the issuance of convertible preferred equity, remain subject to shareholder approval.

Operational Performance and Margins

The revenue decline was primarily driven by lower product revenues, particularly in China, where geopolitical tensions and tariff uncertainty impacted demand. Product revenue fell 42 percent year-over-year to $40.8 million in the quarter. Conversely, service revenue increased 6 percent to $16.1 million, supported by pricing actions and a growing global installed base.

Gross margins expanded to 34.8 percent in the quarter, up from 30.6 percent in the prior year. This improvement included $5.8 million of favorability related to tariff expenses incurred before they were invalidated by the Supreme Court. Excluding this one-time item and a $1.5 million write-down of obsolete components, pro forma gross profit was $30.8 million, or 30.5 percent. Operating expenses decreased 17 percent year-over-year to $29.6 million, excluding $0.7 million in restructuring costs.

What the Numbers Show

The divergence between the EPS beat and the revenue miss highlights a compression in losses rather than operational expansion. While the company narrowed its per-share loss significantly compared to analyst expectations, this was achieved against a backdrop of declining revenue. The 21 percent drop in sales suggests that the EPS beat was driven by cost containment and margin management rather than volume or price-driven growth. Additionally, the substantial reliance on tariff-related favorability for margin expansion indicates that underlying product margins remain under pressure, with pro forma product gross margins standing at 17.5 percent after adjusting for one-time items.

Outlook and Transformation

Accuray is not providing formal revenue guidance for fiscal 2027 due to ongoing geopolitical and macroeconomic uncertainties. However, the company expects continued growth in service revenue and improved service margins driven by pricing optimization. Transformation initiatives delivered more than $20 million in cost and margin improvements in fiscal 2026, surpassing the initial target of $12 million. These efforts are expected to support approximately $15 million of incremental annualized cost and margin improvement in fiscal 2027.

Accuray has announced it will not provide formal revenue or Adjusted EBITDA guidance for fiscal 2027. The decision comes as the company navigates a complex global environment characterized by geopolitical instability and shifting trade policies.

Management highlighted that Accuray is operating from a position of greater strength compared to a year ago. The company expects continued growth in service revenue, driven by pricing optimization and operational efficiencies. Strategic partnerships are also expected to play an increasingly important role in expanding capabilities while allowing the firm to remain focused on its core competencies.

What the Numbers Show

The absence of formal guidance stands in contrast to management's confidence in the business's strengthened position. While specific financial targets are withheld, the expectation of improved service margins and continued benefits from transformation initiatives suggests a focus on operational efficiency over top-line expansion visibility. This divergence indicates that while internal metrics may be improving, external variables such as tariff impacts and conditions in China and the Middle East introduce too much variability for reliable forecasting.

Outlook and Risks

The company pointed to several key factors influencing its decision to withhold guidance:

• Geopolitical developments
• International trade policy changes
• Tariff impacts
• Conditions in China and the Middle East
• Broader macroeconomic factors

Despite these uncertainties, management believes that actions taken during fiscal 2026 have strengthened the business. These measures are expected to improve the company's ability to execute and create long-term value for shareholders.